EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors

Joseph J O'Connor, Dana Ferraris iD, Anthony R Fehr iD

Pathogens · 07.10.2023 · 12 (10) · 1221

DOI: 10.3390/pathogens12101221 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 07.10.2023. Verfasst von Joseph J O'Connor und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, USA. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-structural protein 3 (nsp3) from all coronaviruses (CoVs) contains a conserved macrodomain, known as Mac1, that has been proposed as a potential therapeutic target for CoVs due to its critical role in viral pathogenesis. Mac1 is an ADP-ribose binding protein and ADP-ribosylhydrolase that promotes replication and blocks IFN responses, though the precise mechanisms it uses to carry out these functions remain unknown. Over the past 3 years following the onset of COVID-19, several groups have used high-throughput screening with multiple assays and chemical modifications to create unique chemical inhibitors of the SARS-CoV-2 Mac1 protein. Here, we summarize the current efforts to identify selective and potent inhibitors of SARS-CoV-2 Mac1.

Schlagwörter

Stichwörter der Autor:innen

ADP-ribosylationADP-ribosylhydrolaseMac1SARS-CoV-2coronavirusinhibitorsmacrodomain

Autor:innen und Institutionen

  • Department of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, USA.
  • Department of Chemistry, McDaniel College, 2 College Hill, Westminster, MD 21157, USA.

ORCID-Profile: Dana Ferraris, Anthony R Fehr

Förderung

  • NIGMS NIH HHS
  • NIH

Zitieren

APA

O'Connor, J. J., Ferraris, D., & Fehr, A. R. (2023). An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors. Pathogens, 12(10), 1221. https://doi.org/10.3390/pathogens12101221

Vancouver

O'Connor JJ, Ferraris D, Fehr AR. An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors. Pathogens. 2023;12(10):1221. doi:10.3390/pathogens12101221

BibTeX
@article{OConnor2023,
  author = {O'Connor, Joseph J and Ferraris, Dana and Fehr, Anthony R},
  title = {An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {10},
  pages = {1221},
  doi = {10.3390/pathogens12101221}
}
Kostenlos starten →